It is important to remember that such dogs are not always hostile, only when provoked. Regardless, these breeds have ...
Eli Lilly & Co. is spending another $3 billion to build out its US manufacturing footprint as it ramps up production of its blockbuster diabetes and weight-loss drugs. The latest investment ...
Last month Oppo launched the Pad 3 Pro as a rebranded OnePlus Pad 2, and now the company is getting ready to reveal the non-Pro Pad 3. This one isn't a OnePlus rebrand, and should apparently be ...
Eli Lilly & Co. said its weight-loss drug Zepbound outperformed rival Novo Nordisk A/S’s Wegovy in the first head-to-head trial of the two blockbusters. In a study sponsored by Lilly ...
One of Eli Lilly's potential competitors in the weight loss market just reported unimpressive trial results. The company could benefit from the government coverage of its weight loss medicines.
Eli Lilly announces a $3 billion expansion at its Pleasant Prairie facility, creating 750 jobs. Eli Lilly and Company announced a significant expansion at its Pleasant Prairie facility Thursday.
At just 17, Lily Yohannes has the soccer world at her feet. Considered one of most exciting talents in the women’s game, she is already a regular in Ajax’s first-team and is making waves on ...
Adults taking Zepbound lost 47% more weight on average than those taking Wegovy, according to clinical trial data from drugmaker Eli Lilly. In a head-to-head comparison of the two GLP-1 drugs ...
Now, we already know that Johnny Depp and Vanessa Paradis‘ daughter Lily-Rose Depp is her supermodel mom’s lookalike, but now, Lily-Rose is separating from her and her mom’s usual style and ...
A crochet expert hopes the five metre wide doily she was commissioned to create will make people "recognise crochet as an art", after it made up part of a Turner Prize winning art installation.
"She's incredibly talented. I'm very proud," the actress said of 070 Shake's new album launch Allen Berezovsky/Getty Lily-Rose Depp is happy in love with 070 Shake. The Nosferatu actress ...
Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression to Type 2 diabetes in prediabetic patients, the Indianapolis-based ...